Click image to open full size
Leukemia vs Lymphoma
Cell Lines and Key Differences
Related Tools
Related Labs
Related Worksheets
Related Cheat Sheets
Leukemia and lymphoma are both cancers of white blood cell lineages, but they differ in where they usually begin and how they spread through the body. Leukemia typically starts in the bone marrow and often leads to large numbers of abnormal cells in the blood. Lymphoma usually begins in lymphatic tissues such as lymph nodes, spleen, or other lymphoid organs and may form solid masses. Distinguishing these diseases matters because diagnosis, staging, and treatment planning depend strongly on the cell lineage and site of origin.
The key biological idea is the hematopoietic map: blood cells arise from stem cells in bone marrow, then mature into myeloid or lymphoid lines that circulate or reside in lymphoid tissues. In leukemia, malignant cells often replace normal marrow, reducing production of red cells, platelets, and functional white cells. In lymphoma, malignant lymphocytes usually expand in lymph nodes or extranodal lymphoid tissue before sometimes entering blood or marrow. Cell markers, blood counts, bone marrow findings, and tissue biopsy help determine whether the disease is leukemia, lymphoma, or an overlap syndrome.
Key Facts
- Hematopoietic stem cell -> myeloid lineage + lymphoid lineage
- Leukemia usually arises in bone marrow and commonly involves blood and marrow early.
- Lymphoma usually arises in lymph nodes or other lymphatic tissue and often presents as a mass lesion.
- Anemia is commonly identified when hemoglobin is below about 12 g/dL in many adults, though reference ranges vary by sex and lab.
- Thrombocytopenia is platelet count < 150,000/uL; severe bleeding risk rises markedly at very low counts.
- Normal total white blood cell count is about 4,000 to 11,000/uL, but leukemia may cause counts far above or below this range.
Vocabulary
- Bone marrow
- Bone marrow is the soft tissue inside bones where blood cells are produced from hematopoietic stem cells.
- Lymphocyte
- A lymphocyte is a white blood cell of the immune system that includes B cells, T cells, and NK cells.
- Blast cell
- A blast cell is an immature precursor blood cell that is normally rare in peripheral blood but may increase in acute leukemia.
- Lymph node
- A lymph node is a small immune organ that filters lymph and is a common site where lymphoma begins or enlarges.
- Immunophenotyping
- Immunophenotyping is a lab method that identifies cell types by detecting specific surface markers such as CD antigens.
Common Mistakes to Avoid
- Assuming leukemia is just a blood disease, which is wrong because it usually begins in bone marrow and only secondarily appears in blood. This matters because marrow failure explains anemia, infection risk, and bleeding.
- Assuming lymphoma always stays in lymph nodes, which is wrong because lymphoma can involve spleen, bone marrow, gastrointestinal tract, skin, or blood. Site of disease affects staging and symptoms.
- Confusing myeloid and lymphoid cell lines, which is wrong because these lineages produce different malignancies with different markers and treatments. Students should trace each cancer back to its precursor cell type.
- Thinking a high white blood cell count alone proves leukemia, which is wrong because infection, inflammation, and steroids can also raise the count. Diagnosis requires smear review, immunophenotyping, and often bone marrow or tissue biopsy.
Practice Questions
- 1 A patient has hemoglobin 8.5 g/dL, platelet count 45,000/uL, and white blood cell count 68,000/uL with many blast cells in peripheral blood. Based on the pattern, is leukemia or lymphoma more likely to be the primary process, and which tissue is the likely site of origin?
- 2 A student counts 18,000 white blood cells per uL in a blood sample. Using the normal range 4,000 to 11,000/uL, by how many cells per uL is this value above the upper limit of normal?
- 3 A patient presents with a painless enlarged cervical lymph node, normal peripheral blood smear, and a biopsy showing malignant B lymphocytes. Explain why this presentation fits lymphoma better than leukemia.